Aug 6, 2026 09:12AM
Aug 6, 2026 09:11AM
Aug 6, 2026 09:11AM
Aug 6, 2026 09:10AM
May 22, 2026 09:38AM
May 22, 2026 09:37AM
May 22, 2026 09:36AM TD Cowen on Black Diamond Therapeutics (BDTX) Amid 18% Drop: 'is unclear if the FDA will require Ph3 run-in or additional Ph2 dosing work extending competitor's lead'
May 22, 2026 06:57AM
May 7, 2026 07:54AM
Apr 29, 2026 07:07AM
Mar 23, 2026 06:15AM
Mar 16, 2026 05:05PM
Dec 23, 2025 10:00AM
Dec 4, 2025 07:17AM Black Diamond Therapeutics' (BDTX) Phase 2 Silevertinib Data Encouraging - Stifel
Dec 3, 2025 12:39PM
Oct 15, 2025 04:08PM
Sep 30, 2025 12:18PM
Sep 4, 2025 05:43AM
Aug 11, 2025 06:40AM
Jul 1, 2025 06:24AM
May 13, 2025 06:55AM Black Diamond Therapeutics, Inc. (BDTX) Tops Q1 EPS by 93c
Mar 20, 2025 08:32AM
Mar 19, 2025 07:01AM
Mar 18, 2025 06:39AM
Mar 7, 2025 09:03AM
Mar 6, 2025 05:17PM
Feb 19, 2025 09:16AM
Nov 6, 2024 07:32AM Black Diamond Therapeutics (BDTX) PT Lowered to $16 at Stifel
Nov 5, 2024 08:24AM
Oct 9, 2024 07:21AM
Oct 8, 2024 07:39AM
Oct 7, 2024 04:01PM
Sep 24, 2024 06:48AM
Sep 23, 2024 02:19PM
Sep 23, 2024 08:18AM Black Diamond (BDTX) Climbs 42% Following Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC
Sep 23, 2024 07:02AM
Sep 18, 2024 06:42AM
Sep 16, 2024 07:49AM
Sep 10, 2024 07:44AM
Aug 8, 2024 04:09PM
Aug 6, 2024 08:01AM
Jul 18, 2024 07:51AM Piper Sandler Reiterates Overweight Rating on Black Diamond Therapeutics (BDTX)
Jul 3, 2024 07:14AM

433,992 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All